Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vaneck Biotech ETF (BBH)

Vaneck Biotech ETF (BBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 457,704,200
  • Shares Outstanding, K 2,570
  • 60-Month Beta 0.85
Trade BBH with:
  • Price/Earnings ttm 15.63
  • Annual Dividend & Yield 0.71 (0.40%)
  • Most Recent Dividend 0.713 on 12/18/23
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 17.41% ( +2.20%)
  • Historical Volatility 15.35%
  • IV Percentile 52%
  • IV Rank 39.94%
  • IV High 23.80% on 10/27/23
  • IV Low 13.15% on 05/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 146
  • Open Int (30-Day) 143

Price Performance

See More
Period Period Low Period High Performance
1-Month
166.55 +5.97%
on 07/03/24
180.00 -1.95%
on 07/17/24
+8.24 (+4.90%)
since 06/21/24
3-Month
153.47 +15.00%
on 04/25/24
180.00 -1.95%
on 07/17/24
+19.34 (+12.31%)
since 04/23/24
52-Week
142.51 +23.84%
on 10/31/23
180.00 -1.95%
on 07/17/24
+12.84 (+7.85%)
since 07/21/23

Most Recent Stories

More News
Biogen Earnings Preview: What to Expect

Biogen is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit dip.

BIIB : 224.29 (-1.03%)
$SPX : 5,555.74 (-0.16%)
BBH : 176.49 (-0.90%)
Moderna's Quarterly Earnings Preview: What You Need to Know

Moderna is expected to release its fiscal second-quarter earnings next month, and analysts project a narrower loss.

MRNA : 121.25 (-1.02%)
$SPX : 5,555.74 (-0.16%)
BBH : 176.49 (-0.90%)
What You Need to Know Ahead of Amgen's Earnings Release

Amgen is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit dip.

AMGN : 333.24 (-0.81%)
$SPX : 5,555.74 (-0.16%)
BBH : 176.49 (-0.90%)
Is Wall Street Bullish or Bearish on Moderna Stock?

Moderna has outperformed many of its peers and the broader market YTD, but Wall Street analysts are cautiously optimistic about the stock's prospects.

MRNA : 121.25 (-1.02%)
$SPX : 5,555.74 (-0.16%)
BBH : 176.49 (-0.90%)
What Are Wall Street Analysts' Target Price for Amgen Stock?

Amgen has outperformed the broader market and many of its peers over the past year, but Wall Street analysts believe it has limited upside left.

AMGN : 333.24 (-0.81%)
$SPX : 5,555.74 (-0.16%)
BBH : 176.49 (-0.90%)
VanEck Launches Robotics ETF (IBOT)

VanEck today announced the launch of the VanEck Robotics ETF (IBOT) , a thematic equity ETF offering exposure to the leading global companies that are driving and benefiting from the growth of the robotics...

ESPO : 68.22 (-0.41%)
SMH : 254.86 (-1.11%)
BBH : 176.49 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 180.14
2nd Resistance Point 179.12
1st Resistance Point 178.61
Last Price 176.49
1st Support Level 177.07
2nd Support Level 176.05
3rd Support Level 175.54

See More

52-Week High 180.00
Last Price 176.49
Fibonacci 61.8% 165.68
Fibonacci 50% 161.26
Fibonacci 38.2% 156.83
52-Week Low 142.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar